Protagonist Therapeutics, Inc 8-K

What Happened

• On January 12, 2026, Protagonist Therapeutics, Inc. (PTGX) filed a Current Report on Form 8‑K under Item 7.01 to announce it made an updated corporate presentation available.
• The presentation is filed as Exhibit 99.1 to the 8‑K and the report includes the standard statement that the exhibit is "made available" under Regulation FD.

Key Details

• Filing date: January 12, 2026 (Form 8‑K).
• Item reported: 7.01 — Regulation FD Disclosure.
• Exhibit: 99.1 — Protagonist Therapeutics, Inc. Corporate Presentation, as of January 12, 2026.
• Legal note: The company states the information and exhibit are not to be deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to liability under Sections 11 and 12(a)(2) of the Securities Act.

Why It Matters

• For investors, this is an update to the company's investor presentation and communications—useful for reviewing Protagonist’s strategy, pipeline status, milestones, and any public messaging—but it is not an earnings release, executive change, merger announcement, or a financial results filing.
• The Regulation FD filing means the company publicly distributed this material to ensure fair disclosure; the legal disclaimer clarifies the presentation is not considered a formally "filed" SEC disclosure with the same liability protections.